Impact of leukapheresis on early death rate in adult acute myeloid leukemia presenting with hyperleukocytosis

Transfusion

Volumn 47, Issue 10, 2007, Pages 1843-1850

  Bug, Gesine ^a   Anargyrou, Konstantinos ^b   Tonn, Torsten ^b   Bialleck, Heike ^b   Seifried, Erhard ^b   Hoelzer, Dieter ^b   Ottmann, Oliver G ^b  

^a UNIVERSITY HOSPITAL FRANKFURT   (Germany)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

AMSACRINE; CREATININE; CYTARABINE; DAUNORUBICIN; ETOPOSIDE; GRANULOCYTE COLONY STIMULATING FACTOR; HYDROXYUREA; IDARUBICIN; LACTATE DEHYDROGENASE; MITOXANTRONE; TOPOTECAN;

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER MORTALITY; CANCER SURVIVAL; CLINICAL ARTICLE; CONTINUOUS INFUSION; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DISEASE COURSE; DRUG DOSE REDUCTION; DYSPNEA; FEMALE; FOLLOW UP; HUMAN; HYPERLEUKOCYTOSIS; LACTATE DEHYDROGENASE BLOOD LEVEL; LEUKAPHERESIS; LEUKOCYTOSIS; MALE; MULTIPLE CYCLE TREATMENT; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; OVERALL SURVIVAL; RETROSPECTIVE STUDY; RISK FACTOR; SURVIVAL TIME;

ADULT; AGED; FEMALE; HEMOGLOBINS; HUMANS; LEUKAPHERESIS; LEUKEMIA, MYELOCYTIC, ACUTE; LEUKEMIA, MYELOID; LEUKOCYTE COUNT; LEUKOCYTOSIS; MALE; MIDDLE AGED; PROGNOSIS; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 34548800348     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/j.1537-2995.2007.01406.x     Document Type: Article

References (23)

1. McKee LC Jr., Collins RD. Intravascular leukocyte thrombi and aggregates as a cause of morbidity and mortality in leukemia. Medicine (Baltimore) 1974 53 : 463 78.
2. Porcu P, Cripe LD, Ng EW, Bhatia S, Danielson CM, Orazi A, McCarthy LJ. Hyperleukocytic leukemias and leukostasis: a review of pathophysiology, clinical presentation and management. Leuk Lymphoma 2000 39 : 1 18.
3. Dutcher JP, Schiffer CA, Wiernik PH. Hyperleukocytosis in adult acute nonlymphocytic leukemia: impact on remission rate and duration, and survival. J Clin Oncol 1987 5 : 1364 72.
4. Stucki A, Rivier AS, Gikic M, Monai N, Schapira M, Spertini O. Endothelial cell activation by myeloblasts: molecular mechanisms of leukostasis and leukemic cell dissemination. Blood 2001 97 : 2121 9.
5. Giles FJ, Shen Y, Kantarjian HM, Korbling MJ, O'Brien S, Anderlini P, Donato M, Pierce S, Keating MJ, Freireich EJ, Estey E. Leukapheresis reduces early mortality in patients with acute myeloid leukemia with high white cell counts but does not improve long-term survival. Leuk Lymphoma 2001 42 : 67 73.
6. Porcu P, Danielson CF, Orazi A, Heerema NA, Gabig TG, McCarthy LJ. Therapeutic leukapheresis in hyperleucocytic leukaemias: lack of correlation between degree of cytoreduction and early mortality rate. Br J Haematol 1997 98 : 433 6.
7. Thiebaut A, Thomas X, Belhabri A, Anglaret B, Archimbaud E. Impact of pre-induction therapy leukapheresis on treatment outcome in adult acute myelogenous leukemia presenting with hyperleukocytosis. Ann Hematol 2000 79 : 501 6.
8. Ventura GJ, Hester JP, Smith TL, Keating MJ. Acute myeloblastic leukemia with hyperleukocytosis: risk factors for early mortality in induction. Am J Hematol 1988 27 : 34 7.
9. Lester TJ, Johnson JW, Cuttner J. Pulmonary leukostasis as the single worst prognostic factor in patients with acute myelocytic leukemia and hyperleukocytosis. Am J Med 1985 79 : 43 8.
10. Hug V, Keating M, McCredie K, Hester J, Bodey GP, Freireich EJ. Clinical course and response to treatment of patients with acute myelogenous leukemia presenting with a high leukocyte count. Cancer 1983 52 : 773 9.
11. Bennett JM, Catovsky D, Daniel MT, Flandrin G, Galton DA, Gralnick HR, Sultan C. Proposed revised criteria for the classification of acute myeloid leukemia. A report of the French-American-British Cooperative Group. Ann Intern Med 1985 103 : 620 5.
12. Mitelman F. An international system for human cytogenetic nomenclature. Basel : Karger 1995.
13. Slovak ML, Kopecky KJ, Cassileth PA, Harrington DH, Theil KS, Mohamed A, Paietta E, Willman CL, Head DR, Rowe JM, Forman SJ, Appelbaum FR. Karyotypic analysis predicts outcome of preremission and postremission therapy in adult acute myeloid leukemia: a Southwest Oncology Group/Eastern Cooperative Oncology Group Study. Blood 2000 96 : 4075 83.
14. Heil G, Krauter J, Raghavachar A, Bergmann L, Hoelzer D, Fiedler W, Lübbert M, Noens L, Schlimok G, Arnold R, Kirchner H, Ganser A. Risk-adapted induction and consolidation therapy in adults with de novo AML aged
15. Bergmann L, Heil G, Einsele H, Duerk H, Rhagavachar A, Ganser A, Hoelzer D, Hoechsmann B. A multicenter study with mitoxantrone, topotecan, and cytarabine in patients with relapsed or refractory AML or in CML blast crisis - an interim analysis. Onkologie 2003 26 (Suppl 5 86.
16. Oken MM, Creech RH, Tormey DC, Horton J, Davis TE, McFadden ET, Carbone PP. Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol 1982 5 : 649 55.
17. Arrambide K, Toto RD. Tumor lysis syndrome. Semin Nephrol 1993 13 : 273 80.
18. Creutzig U, Zimmermann M, Reinhardt D, Dworzak M, Stary J, Lehrnbecher T. Early deaths and treatment-related mortality in children undergoing therapy for acute myeloid leukemia: analysis of the multicenter clinical trials AML-BFM 93 and AML-BFM 98. J Clin Oncol 2004 22 : 4384 93.
19. Soares FA, Landell GA, Cardoso MC. Pulmonary leukostasis without hyperleukocytosis. a clinicopathologic study of 16 cases. Am J Hematol 1992 40 : 28 32.
20. Prieto J, Eklund A, Patarroyo M. Regulated expression of integrins and other adhesion molecules during differentiation of monocytes into macrophages. Cell Immunol 1994 156 : 191 211.
21. Diamond MS, Garcia-Aguilar J, Bickford JK, Bickford JK, Corbi AL, Springer TA. The I domain is a major recognition site on the leukocyte integrin Mac-1 (CD11b/CD18) for four distinct adhesion ligands. J Cell Biol 1993 120 : 1031 43.
22. Frick C, Odermatt A, Zen K, Mandell KJ, Edens H, Portmann R, Mazzucchelli L, Jaye DL, Parkos CA. Interaction of ICAM-1 with beta 2-integrin CD11c/CD18: characteriza-tion of a peptide ligand that mimics a putative binding site on domain D4 of ICAM-1. Eur J Immunol 2005 35 : 3610 21.
23. Garnotel R, Rittie L, Poitevin S, Monboisse JC, Nguyen P, Potron G, Maquart FX, Randoux A, Gillery P. Human blood monocytes interact with type I collagen through alpha x beta 2 integrin (CD11c-CD18, gp150-95). J Immunol 2000 164 : 5928 34.